Alopecia aeata: Clinical spectrum and its association with thyroid dysfunction in Bahawalpur

Rabia Asgher, Naima Luqman, Uzma Almas, Akhlaq Akhlaq, Muhammad Khalid, Jamil Ahmed Shaheen

Abstract


Objective To study the clinical spectrum of alopecia areata (AA) and the frequency of thyroid dysfunction in alopecia areata patients.

 

Methods A cross sectional study was carried out in department of Dermatology, Bahawal Victoria Hospital, Bahawalpur for the duration of 6 months. A total of 183 patients suffering from AA of any severity belonging to either sex and age between 20 to 50 were included. All patients were evaluated for severity of AA (mild, moderate, severe, totalis) and their blood samples were taken to analyse thyroid hormones level and antithyroid antibodies.

 

Results Out of 183 patients, 103(56.28%) were males and 80(43.72%) were females. Mean age of patients was 34.80±8.36 years. The mean duration of disease was 6.39±2.44 months. The clinical spectrum of AA was seen as mild in 44.26%, moderate in 39.51%, severe in 15.85% and alopecia totalis in 10.38% patients. The thyroid dysfunction was seen in 13 (7.10%) of AA patients.

 

Conclusion This study concluded that there is high frequency of mild AA and frequency of thyroid dysfunction in AA patients is quite high.

 


Keywords


Alopecia areata, thyroid dysfunction, autoimmunity

Full Text:

PDF

References


Seetharam KA. Alopecia areata: an update. Indian J Dermatol Venereol Leprol. 2013;79:563-75.

Al-Mutairi N, Eldin ON. Clinical profile and impact on quality of life: Seven years experience with patients of alopecia areata. Indian J Dermatol Venereol Leprol. 2011;77:489-93.

Duncan FJ, Silva KA, Johnson C, King B, Szatkiewicz JP, Kamdar S, et al. Endogenous retinoids in the pathogenesis of alopecia areata. J Invest Dermatol. 2013;133(2):334–43.

Gilhar A, Ullmann Y, Berkutzki T, Assay B, Kalish RS. Autoimmune hair loss (alopecia areata) transferred by T lymphocytes to human scalp explants on SCID mice. J Clin Invest 1998;101:62-7.

Bakry OA, Basha MA, El Shafiee MK, Shehata WA. Thyroid disorders associated with alopecia areata in Egyptian patients. Indian J Dermatol. 2014;59(1):49–55.

Alkhalifah A, Alsantali A, Wang E, McElwee KJ, Shapiro J. Alopecia areata update: part i. clinical picture, histopathology and pathogenesis. J Am Acad Dermatol. 2010;62:177-88.

Lo SK, McGuire S, English JC. A retrospective study of thyroid structural abnormalities in alopecia patients. Dermatoendocrinol2011;3:251-4.

Kurtipek GS, Cihan FG, Demirbaş SE, Ataseven A. The frequency of autoimmune thyroid disease in alopecia areata and vitiligo patients. BioMed Res Intl. 2015;2015:435947.

Olsen EA. Investigative guidelines for alopecia areata. Dermatol Therapy. 2011;24:311–19.

Brenner R. Coincidences of alopecia areata, Vitiligo, Onychodystrophy, localized scleroderma and lichen planus. Dermatologica 1979;159:356-8.

Ahmed I, Nasreen S, Jehangir U, Wahid Z. Clinical spectrum of alopecia areata and its association with thyroid dysfunction. J Pak Assoc Dermatol.2012;22(3):207-12.

Ahmed I, Wahid Z, Nasreen S. Alopeciaareata; combination therapy with minoxidil(2%) solution and isotretinoin (0.05%) gel. J Pak Assoc Dermatol 2005;15:140-5.

Jameel K, Ejaz A, Sohail M, Rahman SB.Value of transverse section scalp biopsy in alopecia areata - a clinicopathological correlation. J Coll Physicians Surg Pak. 2008;18:338-41.

Ejaz A, Jameel K, Suhail M. Pattern andprofile of alopecia areata in Pakistan. J Pak Assoc Dermatol 2009;19:136-40.

Puavilai S, Puavilai G, Charuwichitratana S, Sakuntabhai A, Sriprachya-Anunt S. Prevalence of thyroid diseases in patients with alopecia areata. Int J Dermatol. 1994;33:632–3.

Gönül M, Gül U, Pişkin E. Alopesi areatalı hastaların geriye dönük sdeğerlendirilmesi. Turkish J Dermatol. 2011;5:43–47.


Refbacks

  • There are currently no refbacks.


ISSN: 1560-9014